Detection of minimal residual disease in <scp>B</scp> lymphoblastic leukemia using vi<scp>SNE</scp>

Abstract

viSNE shows promise as an automated method to facilitate immunophenotypic MRD detection in patients treated for B lymphoblastic leukemia.